In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Drug:  ibrutinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR101862, PCI-32765MCL4001, NCT01833039

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1112-CA, 2012-000694-23, NCT01578707

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100840, PCI-32765CLL3001, 2012-000600-15, U1111-1135-3745, NCT01611090

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100848, PCI-32765MCL3001, 2012-000601-74, U1111-1135-6930, NCT01646021

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1115-CA, 2012-003967-23, NCT01722487

6.

Phase: Phase III
Type: Treatment
Status: Enrolling by invitation
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1116-CA, 2012-003968-44, NCT01724346

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1102-CA, PCI-32765, NCT01105247

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1109-CA, PCI-32765, NCT01217749

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Other
Protocol IDs: 2012-0086, NCI-2013-00029, NCT01752426

10.

Phase: Phase II
Type: Treatment
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1103-CA, PCI-32765, NCT01109069

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1104-CA, PCI-32765, NCT01236391

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1106-CA, PCI-32765, NCT01325701

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NHLBI
Protocol IDs: 120035, 12-H-0035, NCT01500733

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-0785, NCI-2012-00126, NCT01520519

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100847, PCI-32765MCL2001, 2012-000711-88, NCT01599949

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-015, NCT01614821

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1117-CA, 2012-004476-19, NCT01744691

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00887, MC1282, 9271, N01CM00099, N01CM00032, P30CA015083, NCT01849263

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0090, NCI-2013-01304, NCT01880567

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-04753, NCT00849654

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1108-CA, PCI-32765, NCT01292135

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10052, NCI-2011-03293, NCT01479842

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100844, PCI-32765DBL1002, 2012-000546-35, NCT01569750

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 30 to 55
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100885, PCI-32765CLL1004, 2012-002087-27, NCT01674322

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100896, PCI-32765-JPN-101, NCT01704963
New Search